$WTBA
WEST BANCORPORATION INC

2021 Q1 Form 10-Q Financial Statement

#000116692821000036 Filed on April 29, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $26.31M $25.22M
YoY Change 4.32% 6.63%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $373.0K $375.0K
YoY Change -0.53% 8.7%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $3.189M $6.756M
YoY Change -52.8% -12.96%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $14.82M $10.32M
YoY Change 43.54% 21.94%
Income Tax $3.063M $2.232M
% Of Pretax Income 20.67% 21.63%
Net Earnings $11.75M $8.089M
YoY Change 45.28% 17.25%
Net Earnings / Revenue 44.67% 32.07%
Basic Earnings Per Share $0.71 $0.49
Diluted Earnings Per Share $0.70 $0.49
COMMON SHARES
Basic Shares Outstanding 16.48M shares 16.39M shares
Diluted Shares Outstanding 16.70M shares 16.52M shares

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $325.5M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $29.31M $29.13M
YoY Change 0.61% -4.53%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $9.700M $10.30M
YoY Change -5.83% 90.74%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $3.173B $2.520B
YoY Change 25.93% 8.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $35.90M $43.50M
YoY Change -17.47% 170.19%
Deferred Revenue
YoY Change
Short-Term Debt $4.100M $32.30M
YoY Change -87.31% 82.49%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $35.90M $43.50M
YoY Change -17.47% 170.19%
LONG-TERM LIABILITIES
Long-Term Debt $41.40M $43.30M
YoY Change -4.39% -4.63%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $41.40M $43.30M
YoY Change -4.39% -4.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $35.90M $43.50M
Total Long-Term Liabilities $41.40M $43.30M
Total Liabilities $2.938B $2.319B
YoY Change 26.71% 9.6%
SHAREHOLDERS EQUITY
Retained Earnings $211.8M $189.5M
YoY Change 11.81% 9.3%
Common Stock $3.000M $3.000M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $234.5M $200.7M
YoY Change
Total Liabilities & Shareholders Equity $3.173B $2.520B
YoY Change 25.93% 8.98%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $11.75M $8.089M
YoY Change 45.28% 17.25%
Depreciation, Depletion And Amortization $373.0K $375.0K
YoY Change -0.53% 8.7%
Cash From Operating Activities $15.05M $10.41M
YoY Change 44.54% 56.69%
INVESTING ACTIVITIES
Capital Expenditures $963.0K $174.0K
YoY Change 453.45% 53.98%
Acquisitions
YoY Change
Other Investing Activities -$59.34M -$27.96M
YoY Change 112.23% 1403.23%
Cash From Investing Activities -$60.30M -$28.14M
YoY Change 114.33% 1324.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$25.69M $30.83M
YoY Change -183.33% -769.51%
NET CHANGE
Cash From Operating Activities $15.05M $10.41M
Cash From Investing Activities -$60.30M -$28.14M
Cash From Financing Activities -$25.69M $30.83M
Net Change In Cash -$70.95M $13.11M
YoY Change -641.28% 20064.62%
FREE CASH FLOW
Cash From Operating Activities $15.05M $10.41M
Capital Expenditures $963.0K $174.0K
Free Cash Flow $14.09M $10.24M
YoY Change 37.59% 56.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001166928
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
0-49677
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
WEST BANCORPORATION, INC.
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
IA
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
42-1230603
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1601 22nd Street
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
West Des Moines
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IA
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
50266
CY2021Q1 dei City Area Code
CityAreaCode
(515)
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
222-2300
CY2021Q1 dei Security12b Title
Security12bTitle
Common stock, no par value
CY2021Q1 dei Trading Symbol
TradingSymbol
WTBA
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16554846 shares
CY2021Q1 us-gaap Cash And Due From Banks
CashAndDueFromBanks
23570000 USD
CY2020Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
77693000 USD
CY2021Q1 us-gaap Federal Funds Sold
FederalFundsSold
301919000 USD
CY2020Q4 us-gaap Federal Funds Sold
FederalFundsSold
318742000 USD
CY2021Q1 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
325489000 USD
CY2020Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
396435000 USD
CY2021Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
447152000 USD
CY2020Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
420571000 USD
CY2021Q1 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
12414000 USD
CY2020Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
11723000 USD
CY2021Q1 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
2303999000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
2280575000 USD
CY2021Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
30008000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
29436000 USD
CY2021Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2273991000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2251139000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29308000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29077000 USD
CY2021Q1 us-gaap Interest Receivable
InterestReceivable
12708000 USD
CY2020Q4 us-gaap Interest Receivable
InterestReceivable
11231000 USD
CY2021Q1 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
42906000 USD
CY2020Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
42686000 USD
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9737000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11289000 USD
CY2021Q1 us-gaap Other Assets
OtherAssets
19201000 USD
CY2020Q4 us-gaap Other Assets
OtherAssets
11593000 USD
CY2021Q1 us-gaap Assets
Assets
3172906000 USD
CY2020Q4 us-gaap Assets
Assets
3185744000 USD
CY2021Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
691329000 USD
CY2020Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
696731000 USD
CY2021Q1 us-gaap Interest Bearing Domestic Deposit Demand
InterestBearingDomesticDepositDemand
466913000 USD
CY2020Q4 us-gaap Interest Bearing Domestic Deposit Demand
InterestBearingDomesticDepositDemand
553881000 USD
CY2021Q1 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
1318536000 USD
CY2020Q4 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
1274254000 USD
CY2021Q1 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
45844000 USD
CY2020Q4 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
46907000 USD
CY2021Q1 wtba Timedepositslessthan250000
Timedepositslessthan250000
159471000 USD
CY2020Q4 wtba Timedepositslessthan250000
Timedepositslessthan250000
129221000 USD
CY2021Q1 us-gaap Deposits
Deposits
2682093000 USD
CY2020Q4 us-gaap Deposits
Deposits
2700994000 USD
CY2021Q1 us-gaap Federal Funds Purchased
FederalFundsPurchased
4060000 USD
CY2020Q4 us-gaap Federal Funds Purchased
FederalFundsPurchased
5375000 USD
CY2021Q1 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
20455000 USD
CY2020Q4 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
20452000 USD
CY2021Q1 wtba Federal Home Loan Bank Advances Net Of Discount
FederalHomeLoanBankAdvancesNetOfDiscount
175000000 USD
CY2020Q4 wtba Federal Home Loan Bank Advances Net Of Discount
FederalHomeLoanBankAdvancesNetOfDiscount
175000000 USD
CY2021Q1 us-gaap Other Long Term Debt
OtherLongTermDebt
20919000 USD
CY2020Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
21558000 USD
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
35850000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
38670000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
2938377000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
2962049000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16540381 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16540381 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16469272 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16469272 shares
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
3000000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
3000000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
28243000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
28823000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
211847000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
203718000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8561000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11846000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
234529000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
223695000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3172906000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3185744000 USD
CY2021Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
24038000 USD
CY2020Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
22311000 USD
CY2021Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
1645000 USD
CY2020Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
2383000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
3189000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
6756000 USD
CY2021Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
558000 USD
CY2020Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
297000 USD
CY2021Q1 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
69000 USD
CY2020Q1 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
229000 USD
CY2021Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
26310000 USD
CY2020Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
25220000 USD
CY2021Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
1877000 USD
CY2020Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
5046000 USD
CY2021Q1 us-gaap Interest Expense Federal Funds Purchased
InterestExpenseFederalFundsPurchased
1000 USD
CY2020Q1 us-gaap Interest Expense Federal Funds Purchased
InterestExpenseFederalFundsPurchased
16000 USD
CY2021Q1 us-gaap Interest Expense Subordinated Notes And Debentures
InterestExpenseSubordinatedNotesAndDebentures
249000 USD
CY2020Q1 us-gaap Interest Expense Subordinated Notes And Debentures
InterestExpenseSubordinatedNotesAndDebentures
255000 USD
CY2021Q1 wtba Interest Expense Fhlb Advances
InterestExpenseFHLBAdvances
983000 USD
CY2020Q1 wtba Interest Expense Fhlb Advances
InterestExpenseFHLBAdvances
1309000 USD
CY2021Q1 us-gaap Interest Expense Other Long Term Debt
InterestExpenseOtherLongTermDebt
79000 USD
CY2020Q1 us-gaap Interest Expense Other Long Term Debt
InterestExpenseOtherLongTermDebt
130000 USD
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
23121000 USD
CY2020Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
18464000 USD
CY2021Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
500000 USD
CY2020Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
1000000 USD
CY2021Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
22621000 USD
CY2020Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
17464000 USD
CY2021Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
220000 USD
CY2020Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
158000 USD
CY2021Q1 wtba Loanswapfees
Loanswapfees
0 USD
CY2020Q1 wtba Loanswapfees
Loanswapfees
586000 USD
CY2021Q1 us-gaap Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments
AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments
4000 USD
CY2020Q1 us-gaap Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments
AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments
-6000 USD
CY2021Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
565000 USD
CY2020Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
334000 USD
CY2021Q1 us-gaap Noninterest Income
NoninterestIncome
2465000 USD
CY2020Q1 us-gaap Noninterest Income
NoninterestIncome
2520000 USD
CY2021Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
5608000 USD
CY2020Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
5284000 USD
CY2021Q1 us-gaap Occupancy Net
OccupancyNet
1228000 USD
CY2020Q1 us-gaap Occupancy Net
OccupancyNet
1213000 USD
CY2021Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
602000 USD
CY2020Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
630000 USD
CY2021Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
404000 USD
CY2020Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
237000 USD
CY2021Q1 us-gaap Professional Fees
ProfessionalFees
283000 USD
CY2020Q1 us-gaap Professional Fees
ProfessionalFees
239000 USD
CY2021Q1 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
191000 USD
CY2020Q1 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
234000 USD
CY2021Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1955000 USD
CY2020Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1826000 USD
CY2021Q1 us-gaap Noninterest Expense
NoninterestExpense
10271000 USD
CY2020Q1 us-gaap Noninterest Expense
NoninterestExpense
9663000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14815000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10321000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3063000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2232000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
11752000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
8089000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.49
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.70
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
11752000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
8089000 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-8338000 USD
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
192000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
4000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-6000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
-2102000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
49000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-6240000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
149000 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
7763000 USD
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
-21258000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
-4970000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax
-325000 USD
CY2021Q1 wtba Othercomprehensiveincomelossreclassificationadjustmentfrom Aoc Iforamortizationofderivativeterminationcosts
OthercomprehensiveincomelossreclassificationadjustmentfromAOCIforamortizationofderivativeterminationcosts
0 USD
CY2020Q1 wtba Othercomprehensiveincomelossreclassificationadjustmentfrom Aoc Iforamortizationofderivativeterminationcosts
OthercomprehensiveincomelossreclassificationadjustmentfromAOCIforamortizationofderivativeterminationcosts
-16000 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
3208000 USD
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
-5229000 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
9525000 USD
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-15688000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3285000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-15539000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15037000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7450000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
223695000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
11752000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3285000 USD
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.22
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3623000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
633000 USD
CY2021Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
1213000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
234529000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
211820000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
8089000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-15539000 USD
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.21
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3440000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
512000 USD
CY2020Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
749000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
200693000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
11752000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
8089000 USD
CY2021Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
500000 USD
CY2020Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
1000000 USD
CY2021Q1 wtba Netamortizationandaccretion
Netamortizationandaccretion
382000 USD
CY2020Q1 wtba Netamortizationandaccretion
Netamortizationandaccretion
668000 USD
CY2021Q1 us-gaap Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments
AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments
4000 USD
CY2020Q1 us-gaap Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments
AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments
-6000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
633000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
512000 USD
CY2021Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
220000 USD
CY2020Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
158000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
373000 USD
CY2020Q1 us-gaap Depreciation
Depreciation
375000 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
446000 USD
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
265000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1477000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
424000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2883000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
451000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5547000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
530000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15049000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10412000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
18775000 USD
CY2020Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
39077000 USD
CY2021Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
18577000 USD
CY2020Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
14071000 USD
CY2021Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
72650000 USD
CY2020Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
27190000 USD
CY2021Q1 us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
856000 USD
CY2020Q1 us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
4294000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
165000 USD
CY2020Q1 us-gaap Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
3046000 USD
CY2021Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
23352000 USD
CY2020Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
52672000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
963000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
174000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-60304000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28136000 USD
CY2021Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-18901000 USD
CY2020Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
5369000 USD
CY2021Q1 us-gaap Increase Decrease In Federal Funds Purchased
IncreaseDecreaseInFederalFundsPurchased
1315000 USD
CY2020Q1 us-gaap Increase Decrease In Federal Funds Purchased
IncreaseDecreaseInFederalFundsPurchased
-29680000 USD
CY2021Q1 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
639000 USD
CY2020Q1 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
29000 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3623000 USD
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3440000 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1213000 USD
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
749000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-25691000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30831000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-70946000 USD
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.49
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
13107000 USD
CY2020Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
396435000 USD
CY2019Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
53290000 USD
CY2021Q1 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
325489000 USD
CY2020Q1 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
66397000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
3531000 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
6768000 USD
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
In preparing the consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses for the reporting period. Actual results could differ from those estimates. Material estimates that are particularly susceptible to significant change in the near term are the fair value of financial instruments and the allowance for loan losses
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
11752000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
8089000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16475000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16386000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
226000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
131000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16701000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16517000 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.70
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
67000 shares
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
157000 shares
CY2021Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
447482000 USD
CY2021Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
6906000 USD
CY2021Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
7236000 USD
CY2021Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
447152000 USD
CY2020Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
412559000 USD
CY2020Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
9792000 USD
CY2020Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1780000 USD
CY2020Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
420571000 USD
CY2021Q1 us-gaap Pledged Financial Instruments Not Separately Reported Securities Pledged
PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesPledged
265001000 USD
CY2020Q4 us-gaap Pledged Financial Instruments Not Separately Reported Securities Pledged
PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesPledged
232206000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenAmortizedCostBasis
11330000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue
11159000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Rolling After Year Ten Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRollingAfterYearTenAmortizedCostBasis
196171000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Rolling After Year Ten Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingAfterYearTenFairValue
193942000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
207501000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
205101000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
239981000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
242051000 USD
CY2021Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
447482000 USD
CY2021Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
447152000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
18775000 USD
CY2020Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
39077000 USD
CY2021Q1 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
162000 USD
CY2020Q1 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
899000 USD
CY2021Q1 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
158000 USD
CY2020Q1 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
905000 USD
CY2021Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
175015000 USD
CY2021Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
6534000 USD
CY2021Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
42128000 USD
CY2021Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
702000 USD
CY2021Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
217143000 USD
CY2021Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
7236000 USD
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
86877000 USD
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
868000 USD
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
32026000 USD
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
912000 USD
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
118903000 USD
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
1780000 USD
CY2021Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2311073000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2286749000 USD
CY2021Q1 us-gaap Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums
UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums
-7074000 USD
CY2020Q4 us-gaap Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums
UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums
-6174000 USD
CY2021Q1 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
2303999000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
2280575000 USD
CY2021Q1 wtba Covid19 Loan Modification
COVID19LoanModification
109078000 USD
CY2020Q4 wtba Troubled Debt Restructured Loans Includedin Nonaccrual
TroubledDebtRestructuredLoansIncludedinNonaccrual
0 USD
CY2021Q1 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
0 USD
CY2020Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
0 USD
CY2021Q1 wtba Troubled Debt Restructured Loans Includedin Nonaccrual
TroubledDebtRestructuredLoansIncludedinNonaccrual
0 USD
CY2020Q1 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0 loans
CY2021Q1 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0 loans
CY2020 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0 loans
CY2021 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0 loans
CY2021Q1 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
371000 USD
CY2021Q1 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
371000 USD
CY2020Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
377000 USD
CY2020Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
377000 USD
CY2021Q1 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
15817000 USD
CY2021Q1 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
15817000 USD
CY2020Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
15817000 USD
CY2020Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
15817000 USD
CY2021Q1 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
16188000 USD
CY2021Q1 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
16188000 USD
CY2021Q1 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
3000000 USD
CY2020Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
16194000 USD
CY2020Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
16194000 USD
CY2020Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
3000000 USD
CY2021Q1 wtba Number Of Borrowers Impaired Loans
NumberOfBorrowersImpairedLoans
2 Borrowers
CY2020Q4 wtba Number Of Borrowers Impaired Loans
NumberOfBorrowersImpairedLoans
2 Borrowers
CY2020Q4 wtba Loans Impaired Commitmentto Lend
LoansImpairedCommitmenttoLend
0 USD
CY2021Q1 wtba Loans Impaired Commitmentto Lend
LoansImpairedCommitmenttoLend
0 USD
CY2021Q1 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
374000 USD
CY2021Q1 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
0 USD
CY2020Q1 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
505000 USD
CY2020Q1 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
5000 USD
CY2021Q1 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
15817000 USD
CY2021Q1 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
0 USD
CY2020Q1 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
0 USD
CY2020Q1 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
0 USD
CY2021Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
16191000 USD
CY2021Q1 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
0 USD
CY2020Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
505000 USD
CY2020Q1 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
5000 USD
CY2021Q1 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
8651000 USD
CY2021Q1 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
2286234000 USD
CY2021Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
16188000 USD
CY2021Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2311073000 USD
CY2020Q4 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
18000 USD
CY2020Q4 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
2270537000 USD
CY2020Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
16194000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2286749000 USD
CY2021Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2311073000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2286749000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
29436000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
0 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
72000 USD
CY2021Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
500000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
30008000 USD
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
17235000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
1000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
98000 USD
CY2020Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
1000000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
18332000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
3000000 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
27008000 USD
CY2021Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
30008000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
3000000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
26436000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
29436000 USD
CY2021Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
16188000 USD
CY2021Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
2294885000 USD
CY2021Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2311073000 USD
CY2020Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
16194000 USD
CY2020Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
2270555000 USD
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2286749000 USD
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
7562000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
7418000 USD
CY2021Q1 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
83000 USD
CY2020Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
0 USD
CY2021Q1 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
2802000 USD
CY2020Q4 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
6010000 USD
CY2021Q1 wtba Deferredtaxassetsleaseliabilities
Deferredtaxassetsleaseliabilities
1846000 USD
CY2020Q4 wtba Deferredtaxassetsleaseliabilities
Deferredtaxassetsleaseliabilities
1919000 USD
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
184000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
352000 USD
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
385000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
763000 USD
CY2021Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1218000 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1197000 USD
CY2021Q1 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
35000 USD
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
37000 USD
CY2021Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
14115000 USD
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
17696000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
1790000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
1863000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Financing Costs
DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts
257000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Financing Costs
DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts
256000 USD
CY2021Q1 wtba Deferred Tax Liabilities Unrealized Gainson Availablefor Sale Securities
DeferredTaxLiabilitiesUnrealizedGainsonAvailableforSaleSecurities
0 USD
CY2020Q4 wtba Deferred Tax Liabilities Unrealized Gainson Availablefor Sale Securities
DeferredTaxLiabilitiesUnrealizedGainsonAvailableforSaleSecurities
2019000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
855000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
801000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
258000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
271000 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3160000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
5210000 USD
CY2021Q1 wtba Deferred Tax Assets Net Before Valuation Allowance
DeferredTaxAssetsNetBeforeValuationAllowance
10955000 USD
CY2020Q4 wtba Deferred Tax Assets Net Before Valuation Allowance
DeferredTaxAssetsNetBeforeValuationAllowance
12486000 USD
CY2021Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1218000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1197000 USD
CY2021Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
9737000 USD
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
11289000 USD
CY2021Q1 us-gaap Unused Commitments To Extend Credit
UnusedCommitmentsToExtendCredit
844593000 USD
CY2020Q4 us-gaap Unused Commitments To Extend Credit
UnusedCommitmentsToExtendCredit
855885000 USD
CY2021Q1 wtba Fhlbmpf Program Remaining Outstanding Balanceof Loans Sold
FHLBMPFProgramRemainingOutstandingBalanceofLoansSold
39811000 USD
CY2020Q4 wtba Fhlbmpf Program Remaining Outstanding Balanceof Loans Sold
FHLBMPFProgramRemainingOutstandingBalanceofLoansSold
43847000 USD
CY2021Q1 wtba Transfers Between Levels Fair Value Disclosure
TransfersBetweenLevelsFairValueDisclosure
0 USD
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.70
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
8089000 USD
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2021Q1 wtba Covid19 Loan Modification
COVID19LoanModification
109078000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
11752000 USD
CY2021Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
500000 USD

Files In Submission

Name View Source Status
0001166928-21-000036-index-headers.html Edgar Link pending
0001166928-21-000036-index.html Edgar Link pending
0001166928-21-000036.txt Edgar Link pending
0001166928-21-000036-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wtba-20210331.htm Edgar Link pending
wtba-20210331.xsd Edgar Link pending
wtba-20210331xex311.htm Edgar Link pending
wtba-20210331xex312.htm Edgar Link pending
wtba-20210331xex321.htm Edgar Link pending
wtba-20210331xex322.htm Edgar Link pending
wtba-20210331_cal.xml Edgar Link unprocessable
wtba-20210331_def.xml Edgar Link unprocessable
wtba-20210331_htm.xml Edgar Link completed
wtba-20210331_lab.xml Edgar Link unprocessable
wtba-20210331_pre.xml Edgar Link unprocessable